1094510-28-7

Basic information

• Product Name: (4-BroMo-2-propoxyphenyl)Methanol
• Synonyms: (4-BroMo-2-propoxyphenyl)Methanol;4-bromo-2-propoxybenzenemethanol
• CAS NO: 1094510-28-7
• Molecular Formula: C₁₀H₁₃BrO₂
• Molecular Weight: 245.11302
• Mol File: 1094510-28-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4-BroMo-2-propoxyphenyl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-BroMo-2-propoxyphenyl)Methanol(1094510-28-7)
• EPA Substance Registry System: (4-BroMo-2-propoxyphenyl)Methanol(1094510-28-7)

Safety Data

• Hazardous Substances Data: 1094510-28-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(4-Bromo-2-propoxyphenyl)Methanol is used as an intermediate in the synthesis of various pharmaceutical products for its versatile reactivity and ability to be a building block in the production of specialty chemicals.
Used in Organic Compounds Production:
(4-Bromo-2-propoxyphenyl)Methanol is used as a key component in the production of other organic compounds due to its unique properties and reactivity.
Safety Note:
(4-Bromo-2-propoxyphenyl)Methanol is considered to be a potentially hazardous substance and should be handled with care in a controlled laboratory setting to ensure safety and proper usage.

Upstream product

• 1094555-01-7 4-bromo-2-propoxybenzaldehyde 

Downstream Products

• 1160431-15-1 4-bromo-1-(bromomethyl)-2-(propyloxy)benzene 

Relevant articles and documents

THIAZOLE COMPOUNDS AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE

Disclosed are compounds of formula (I) wherein R1 and R2 are independently selected from hydrogen, halo, C1-4alkyl, C1-4alkoxy, CF3 and OCF3; -Y- represents formula (IA) R3 represents hydrogen, fluoro, chloro or C1-4alkyl; R4a and R4b each independently represent hydrogen, C1-4alkyl, C1-4alkoxy, CF3 or halo; and R5 represents a group Z-X; wherein Z is absent or represents (CH2)2 or O; and X represents formula (IB) wherein: J and L both represent CH, or one of J and L represents CH and the other represents N; when both J and L represent CH, R6 represents hydrogen, halo, CF3, C1-4alkyl or C1-4alkoxy in a meta or ortho position relative to the R7 substituent and R7 represents hydrogen, halo, CF3, OCF3, C1-4alkyl, C1-4alkoxy, CH2OH, CN, CONR8R9 or CO2H; or when one of J or L represents N, R6 represents hydrogen or halo in a meta or ortho position relative to the R7 substituent and R7 represents hydrogen, halo, CF3, C1-4alkyl, C1-4alkoxy, CH2OH, CN, CONR8R9 or CO2H; and R8 and R9 are independently selected from hydrogen and C1-4alkyl; or salts thereof which activate soluble guanylate cyclase (sGC), pharmaceutical compositions containing them, their use in medicine, and processes for their preparation.

PYRIMIDINE DERIVATIVES AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE

Disclosed are compounds of formula (I) and or salts thereof which activate soluble guanylate cyclase (sGC), pharmaceutical compositions containing them, their use in the manufacture of a medicament for teating cardiovascular diseases, and processes for their preparation.

2,6-DISUBSTITUTED PYRIDINES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

Disclosed are compounds of formula (I) wherein R1 and R2 are independently selected from hydrogen, halo, CF3, C1-4alkyl and allyl; Y represents (II), (III), (IV) or (V) wherein R3 represents CF3 or C1-4alkyl; and R3a represents CF3 or C1-4alkyl.